{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:17:04Z","timestamp":1790047024745,"version":"4.0.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870166"],"award-info":[{"award-number":["81870166"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ50706"],"award-info":[{"award-number":["2025JJ50706"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"\u201cco-PI\u201d project from The Third Xiangya Hospital of Central South University","award":["202408"],"award-info":[{"award-number":["202408"]}]},{"name":"Natural Science Foundation of Changsha City","award":["kq2502026"],"award-info":[{"award-number":["kq2502026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02340-7","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T06:54:26Z","timestamp":1752821666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["MIR4726EccDNA drives bortezomib resistance in multiple myeloma by enhancing MIR4726-5p\/NXF1\/NKIRAS2 axis dependent autophagy"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2372-3251","authenticated-orcid":false,"given":"Fangfang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sishi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9245-316X","authenticated-orcid":false,"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1319-4938","authenticated-orcid":false,"given":"Yunfeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"1","key":"2340_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13045-019-0706-9","volume":"12","author":"W Liu","year":"2019","unstructured":"Liu W, Liu J, Song Y, Wang X, Zhou M, et al. Mortality of lymphoma and myeloma in china, 2004\u20132017: an observational study. J Hematol Oncol. 2019;12(1):22.","journal-title":"J Hematol Oncol"},{"key":"2340_CR2","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3389\/fonc.2019.01513","volume":"9","author":"S Wang","year":"2020","unstructured":"Wang S, Xu L, Feng J, Liu Y, Liu L, Wang J, et al. Prevalence and incidence of multiple myeloma in urban area in china: A National Population-Based analysis. Front Oncol. 2020;9:1513.","journal-title":"Front Oncol"},{"issue":"10272","key":"2340_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"397","author":"NWCJ Van De Donk","year":"2021","unstructured":"Van De Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397(10272):410\u201327.","journal-title":"Lancet"},{"issue":"27","key":"2340_CR4","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1200\/JCO.2008.20.6136","volume":"27","author":"H Avet-Loiseau","year":"2009","unstructured":"Avet-Loiseau H, Li C, Magrangeas F, Gouraud W, Charbonnel C, Harousseau JL, et al. Prognostic significance of Copy-Number alterations in multiple myeloma. JCO. 2009;27(27):4585\u201390.","journal-title":"JCO"},{"issue":"2","key":"2340_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/leu.2013.247","volume":"28","author":"WJ Chng","year":"2014","unstructured":"Chng WJ, Dispenzieri A, Chim CS, Fonseca R, Goldschmidt H, Lentzsch S, et al. IMWG consensus on risk stratification in multiple myeloma. Leukemia. 2014;28(2):269\u201377.","journal-title":"Leukemia"},{"issue":"2","key":"2340_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2796.2010.02324.x","volume":"269","author":"H Nahi","year":"2011","unstructured":"Nahi H, Sutlu T, Jansson M, Alici E, Gahrton G. Clinical impact of chromosomal aberrations in multiple myeloma: review: impact of chromosomal aberrations in MM. J Intern Med. 2011;269(2):137\u201347.","journal-title":"J Intern Med"},{"issue":"16","key":"2340_CR7","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1200\/JCO.2011.36.5726","volume":"30","author":"H Avet-Loiseau","year":"2012","unstructured":"Avet-Loiseau H, Attal M, Campion L, Caillot D, Hulin C, Marit G, et al. Long-Term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining Long-Term survival. JCO. 2012;30(16):1949\u201352.","journal-title":"JCO"},{"issue":"12","key":"2340_CR8","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1038\/leu.2011.162","volume":"25","author":"AM Halld\u00f3rsd\u00f3ttir","year":"2011","unstructured":"Halld\u00f3rsd\u00f3ttir AM, Lundin A, Murray F, Mansouri L, Knuutila S, Sundstr\u00f6m C, et al. Impact of TP53 mutation and 17p deletion in mantle cell lymphoma. Leukemia. 2011;25(12):1904\u20138.","journal-title":"Leukemia"},{"issue":"9","key":"2340_CR9","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1158\/1078-0432.CCR-14-2576","volume":"21","author":"G An","year":"2015","unstructured":"An G, Li Z, Tai YT, Acharya C, Li Q, Qin X, et al. The impact of clone size on the prognostic value of chromosome aberrations by fluorescence in situ hybridization in multiple myeloma. Clin Cancer Res. 2015;21(9):2148\u201356.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2340_CR10","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1038\/s41467-019-11680-1","volume":"10","author":"F Maura","year":"2019","unstructured":"Maura F, Bolli N, Angelopoulos N, Dawson KJ, Leongamornlert D, Martincorena I, et al. Genomic landscape and chronological reconstruction of driver events in multiple myeloma. Nat Commun. 2019;10(1):3835.","journal-title":"Nat Commun"},{"issue":"1","key":"2340_CR11","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1038\/ncomms3997","volume":"5","author":"N Bolli","year":"2014","unstructured":"Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, Martincorena I, et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun. 2014;5(1):2997.","journal-title":"Nat Commun"},{"issue":"1","key":"2340_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41392-022-01176-8","volume":"7","author":"L Yang","year":"2022","unstructured":"Yang L, Jia R, Ge T, Ge S, Zhuang A, Chai P, et al. Extrachromosomal circular DNA: biogenesis, structure, functions and diseases. Signal Transduct Target Therapy. 2022;7(1):342.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"2340_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12943-021-01413-8","volume":"20","author":"X Ling","year":"2021","unstructured":"Ling X, Han Y, Meng J, Zhong B, Chen J, Zhang H, et al. Small extrachromosomal circular DNA (eccDNA): major functions in evolution and cancer. Mol Cancer. 2021;20(1):113.","journal-title":"Mol Cancer"},{"issue":"2","key":"2340_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41588-021-01000-z","volume":"54","author":"E Van Leen","year":"2022","unstructured":"Van Leen E, Br\u00fcckner L, Henssen AG. The genomic and Spatial mobility of extrachromosomal DNA and its implications for cancer therapy. Nat Genet. 2022;54(2):107\u201314.","journal-title":"Nat Genet"},{"issue":"1","key":"2340_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.molcel.2021.11.027","volume":"82","author":"RA Henriksen","year":"2022","unstructured":"Henriksen RA, Jenjaroenpun P, Sj\u00f8str\u00f8m IB, Jensen KR, Prada-Luengo I, Wongsurawat T, et al. Circular DNA in the human germline and its association with recombination. Mol Cell. 2022;82(1):209\u2013e2177.","journal-title":"Mol Cell"},{"issue":"1","key":"2340_CR16","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/s41467-018-03369-8","volume":"9","author":"HD M\u00f8ller","year":"2018","unstructured":"M\u00f8ller HD, Mohiyuddin M, Prada-Luengo I, Sailani MR, Halling JF, Plomgaard P, et al. Circular DNA elements of chromosomal origin are common in healthy human somatic tissue. Nat Commun. 2018;9(1):1069.","journal-title":"Nat Commun"},{"issue":"7254","key":"2340_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature08170","volume":"460","author":"SW Chi","year":"2009","unstructured":"Chi SW, Zang JB, Mele A, Darnell RB. Argonaute HITS-CLIP decodes microRNA\u2013mRNA interaction maps. Nature. 2009;460(7254):479\u201386.","journal-title":"Nature"},{"issue":"3","key":"2340_CR18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.cell.2013.03.043","volume":"153","author":"A Helwak","year":"2013","unstructured":"Helwak A, Kudla G, Dudnakova T, Tollervey D. Mapping the human MiRNA interactome by CLASH reveals frequent noncanonical binding. Cell. 2013;153(3):654\u201365.","journal-title":"Cell"},{"issue":"4","key":"2340_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41419-023-05755-7","volume":"14","author":"Y Yang","year":"2023","unstructured":"Yang Y, Yang Y, Huang H, Song T, Mao S, Liu D, et al. PLCG2 can exist in EccDNA and contribute to the metastasis of non-small cell lung cancer by regulating mitochondrial respiration. Cell Death Dis. 2023;14(4):257.","journal-title":"Cell Death Dis"},{"issue":"2","key":"2340_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41419-022-04627-w","volume":"13","author":"C Lin","year":"2022","unstructured":"Lin C, Chen Y, Zhang F, Liu B, Xie C, Song Y. Encoding gene RAB3B exists in linear chromosomal and circular extrachromosomal DNA and contributes to cisplatin resistance of hypopharyngeal squamous cell carcinoma via inducing autophagy. Cell Death Dis. 2022;13(2):171.","journal-title":"Cell Death Dis"},{"issue":"7","key":"2340_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00018-023-04838-0","volume":"80","author":"X Jiang","year":"2023","unstructured":"Jiang X, Pan X, Li W, Han P, Yu J, Li J, et al. Genome-wide characterization of extrachromosomal circular DNA in gastric cancer and its potential role in carcinogenesis and cancer progression. Cell Mol Life Sci. 2023;80(7):191.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"2340_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41419-022-04807-8","volume":"13","author":"Y Cen","year":"2022","unstructured":"Cen Y, Fang Y, Ren Y, Hong S, Lu W, Xu J. Global characterization of extrachromosomal circular DNAs in advanced high grade serous ovarian cancer. Cell Death Dis. 2022;13(4):342.","journal-title":"Cell Death Dis"},{"key":"2340_CR23","doi-asserted-by":"publisher","first-page":"934159","DOI":"10.3389\/fonc.2022.934159","volume":"12","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Liu Z, Guo Y, Li S, Qu Y, Dai L, et al. Whole-genome sequencing of extrachromosomal circular DNA of cerebrospinal fluid of Medulloblastoma. Front Oncol. 2022;12:934159.","journal-title":"Front Oncol"},{"issue":"1","key":"2340_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s43556-022-00104-0","volume":"3","author":"Z Chen","year":"2022","unstructured":"Chen Z, Qi Y, He J, Xu C, Ge Q, Zhuo W, et al. Distribution and characterization of extrachromosomal circular DNA in colorectal cancer. Mol Biomed. 2022;3(1):38.","journal-title":"Mol Biomed"},{"issue":"1","key":"2340_CR25","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng Y, Croce CM. The role of MicroRNAs in human cancer. Sig Transduct Target Ther. 2016;1(1):15004.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"2340_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-017-0492-1","volume":"10","author":"N Rastgoo","year":"2017","unstructured":"Rastgoo N, Abdi J, Hou J, Chang H. Role of epigenetics-microRNA axis in drug resistance of multiple myeloma. J Hematol Oncol. 2017;10(1):121.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"2340_CR27","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1093\/nar\/gkz155","volume":"47","author":"T Paulsen","year":"2019","unstructured":"Paulsen T, Shibata Y, Kumar P, Dillon L, Dutta A. Small extrachromosomal circular dnas, microdna, produce short regulatory RNAs that suppress gene expression independent of canonical promoters. Nucleic Acids Res. 2019;47(9):4586\u201396.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2340_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/HEP.0000000000000435","volume":"79","author":"S Zou","year":"2024","unstructured":"Zou S, Chen S, Rao G, Zhang G, Ma M, Peng B, et al. Extrachromosomal circular MiR-17-92 amplicon promotes HCC. Hepatology. 2024;79(1):79\u201395.","journal-title":"Hepatology"},{"key":"2340_CR29","doi-asserted-by":"publisher","first-page":"116185","DOI":"10.1016\/j.bone.2021.116185","volume":"154","author":"B Hu","year":"2022","unstructured":"Hu B, Xiao L, Wang C, Liu C, Zhang Y, Ding B, et al. Circ_0022382 ameliorated intervertebral disc degeneration by regulating TGF-\u03b23 expression through sponge adsorption of miR-4726-5p. Bone. 2022;154:116185.","journal-title":"Bone"},{"issue":"1","key":"2340_CR30","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/21691401.2016.1138487","volume":"45","author":"B Tayebi","year":"2017","unstructured":"Tayebi B, Abrishami F, Alizadeh S, Minayi N, Mohammadian M, Soleimani M, et al. Modulation of MicroRNAs expression in hematopoietic stem cells treated with sodium butyrate in inducing fetal hemoglobin expression. Artif Cells Nanomed Biotechnol. 2017;45(1):146\u201356.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"2340_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12872-020-01346-y","volume":"20","author":"W Yadi","year":"2020","unstructured":"Yadi W, Shurui C, Tong Z, Suxian C, Qing T, Dongning H. Bioinformatic analysis of peripheral blood MiRNA of breast cancer patients in relation with anthracycline cardiotoxicity. BMC Cardiovasc Disord. 2020;20(1):43.","journal-title":"BMC Cardiovasc Disord"},{"key":"2340_CR32","doi-asserted-by":"publisher","first-page":"120163","DOI":"10.1016\/j.envpol.2022.120163","volume":"313","author":"J Guo","year":"2022","unstructured":"Guo J, Xie X, Wu J, Yang L, Ruan Q, Xu X, et al. Association between fine particulate matter and coronary heart disease: A MiRNA microarray analysis. Environ Pollut. 2022;313:120163.","journal-title":"Environ Pollut"},{"key":"2340_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.omtn.2022.07.001","volume":"29","author":"M Doke","year":"2022","unstructured":"Doke M, McLaughlin JP, Cai JJ, Pendyala G, Kashanchi F, Khan MA, et al. HIV-1 Tat and cocaine impact astrocytic energy reservoirs and epigenetic regulation by influencing the LINC01133-hsa-miR-4726-5p-NDUFA9 axis. Mol Therapy - Nucleic Acids. 2022;29:243\u201358.","journal-title":"Mol Therapy - Nucleic Acids"},{"issue":"1","key":"2340_CR34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1158\/0008-5472.CAN-10-1869","volume":"71","author":"H Persson","year":"2011","unstructured":"Persson H, Kvist A, Rego N, Staaf J, Vallon-Christersson J, Luts L, et al. Identification of new MicroRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2\/Her2 gene. Cancer Res. 2011;71(1):78\u201386.","journal-title":"Cancer Res"},{"issue":"4","key":"2340_CR35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/mc.23389","volume":"61","author":"Q Tang","year":"2022","unstructured":"Tang Q, Li X, Chen Y, Long S, Yu Y, Sheng H, et al. Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of Sorafenib by regulating HOTTIP-TUG1\/miR\u20104726\u20105p\/MUC1 pathway. Mol Carcinog. 2022;61(4):417\u201332.","journal-title":"Mol Carcinog"},{"issue":"2","key":"2340_CR36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.molcel.2020.05.013","volume":"79","author":"B Zuckerman","year":"2020","unstructured":"Zuckerman B, Ron M, Mikl M, Segal E, Ulitsky I. Gene architecture and sequence composition underpin selective dependency of nuclear export of long RNAs on NXF1 and the TREX complex. Mol Cell. 2020;79(2):251\u2013e2676.","journal-title":"Mol Cell"},{"issue":"1","key":"2340_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.molcel.2019.01.026","volume":"74","author":"S Chen","year":"2019","unstructured":"Chen S, Wang R, Zheng D, Zhang H, Chang X, Wang K, et al. The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation, and mRNA export. Mol Cell. 2019;74(1):118\u2013e1317.","journal-title":"Mol Cell"},{"issue":"1","key":"2340_CR38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-023-01649-4","volume":"8","author":"Y Yang","year":"2023","unstructured":"Yang Y, Guo L, Chen L, Gong B, Jia D, Sun Q. Nuclear transport proteins: structure, function, and disease relevance. Signal Transduct Target Therapy. 2023;8(1):425.","journal-title":"Signal Transduct Target Therapy"},{"issue":"9","key":"2340_CR39","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1158\/2159-8290.CD-21-0862","volume":"11","author":"E Wang","year":"2021","unstructured":"Wang E, Abdel-Wahab O. mRNA export as a novel Cancer-Specific dependency. Cancer Discov. 2021;11(9):2129\u201331.","journal-title":"Cancer Discov"},{"issue":"10","key":"2340_CR40","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrm2255","volume":"8","author":"A K\u00f6hler","year":"2007","unstructured":"K\u00f6hler A, Hurt E. Exporting RNA from the nucleus to the cytoplasm. Nat Rev Mol Cell Biol. 2007;8(10):761\u201373.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"2340_CR41","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1182\/bloodadvances.2019001323","volume":"4","author":"S Chappaz","year":"2020","unstructured":"Chappaz S, Law CW, Dowling MR, Carey KT, Lane RM, Ngo LH, et al. Germline heterozygous mutations in Nxf1 perturb RNA metabolism and trigger thrombocytopenia and lymphopenia in mice. Blood Adv. 2020;4(7):1270\u201383.","journal-title":"Blood Adv"},{"key":"2340_CR42","doi-asserted-by":"crossref","unstructured":"Jin T, Yang L, Chang C, Luo H, Wang R, Gan Y et al. HnRNPA2B1 isgylation regulates m6A-Tagged mRNA selective export via ALYREF\/NXF1 complex to foster breast Cancer development. Adv Sci. 2024;11(24):e2307639.","DOI":"10.1002\/advs.202307639"},{"key":"2340_CR43","doi-asserted-by":"publisher","first-page":"1125299","DOI":"10.3389\/fendo.2023.1125299","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Wang H, Pan Y, Wang S, Zhang Z, Zhou H, et al. Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer. Front Endocrinol. 2023;14:1125299.","journal-title":"Front Endocrinol"},{"issue":"7","key":"2340_CR44","first-page":"3071","volume":"61","author":"T Hideshima","year":"2001","unstructured":"Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, Adams J, et al. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res. 2001;61(7):3071\u20136.","journal-title":"Cancer Res"},{"issue":"21","key":"2340_CR45","doi-asserted-by":"publisher","first-page":"16096","DOI":"10.1074\/jbc.M109.072694","volume":"285","author":"C Li","year":"2010","unstructured":"Li C, Chen S, Yue P, Deng X, Lonial S, Khuri FR, et al. Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradation. J Biol Chem. 2010;285(21):16096\u2013104.","journal-title":"J Biol Chem"},{"issue":"5454","key":"2340_CR46","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1126\/science.287.5454.869","volume":"287","author":"C Fenwick","year":"2000","unstructured":"Fenwick C, Na SY, Voll RE, Zhong H, Im SY, Lee JW, et al. A subclass of Ras proteins that regulate the degradation of I\u03baB. Science. 2000;287(5454):869\u201373.","journal-title":"Science"},{"issue":"40","key":"2340_CR47","doi-asserted-by":"publisher","first-page":"30622","DOI":"10.1074\/jbc.M110.117028","volume":"285","author":"K Tago","year":"2010","unstructured":"Tago K, Funakoshi-Tago M, Sakinawa M, Mizuno N, Itoh H. KappaB-Ras is a nuclear-cytoplasmic small GTPase that inhibits NF-kappaB activation through the suppression of transcriptional activation of p65\/RelA. J Biol Chem. 2010;285(40):30622\u201333.","journal-title":"J Biol Chem"},{"issue":"6","key":"2340_CR48","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.celrep.2014.08.015","volume":"8","author":"A Oeckinghaus","year":"2014","unstructured":"Oeckinghaus A, Postler TS, Rao P, Schmitt H, Schmitt V, Grinberg-Bleyer Y, et al. \u03baB-Ras proteins regulate both NF-\u03baB-Dependent inflammation and Ral-Dependent proliferation. Cell Rep. 2014;8(6):1793\u2013807.","journal-title":"Cell Rep"},{"issue":"1","key":"2340_CR49","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1038\/s41467-020-17226-0","volume":"11","author":"S Beel","year":"2020","unstructured":"Beel S, Kolloch L, Apken LH, J\u00fcrgens L, Bolle A, Sudhof N, et al. \u03baB-Ras and Ral GTPases regulate acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis. Nat Commun. 2020;11(1):3409.","journal-title":"Nat Commun"},{"issue":"1","key":"2340_CR50","doi-asserted-by":"publisher","first-page":"20658","DOI":"10.1038\/s41598-021-00200-1","volume":"11","author":"K Tago","year":"2021","unstructured":"Tago K, Ohta S, Aoki-Ohmura C, Funakoshi-Tago M, Sashikawa M, Matsui T, et al. K15 promoter-driven enforced expression of NKIRAS exhibits tumor suppressive activity against the development of DMBA\/TPA-induced skin tumors. Sci Rep. 2021;11(1):20658.","journal-title":"Sci Rep"},{"issue":"6","key":"2340_CR51","doi-asserted-by":"publisher","first-page":"e1279","DOI":"10.1038\/cddis.2014.245","volume":"5","author":"S Haemmig","year":"2014","unstructured":"Haemmig S, Baumgartner U, Gl\u00fcck A, Zbinden S, Tschan MP, Kappeler A, et al. miR-125b controls apoptosis and Temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas. Cell Death Dis. 2014;5(6):e1279\u20131279.","journal-title":"Cell Death Dis"},{"key":"2340_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2019.01.022","volume":"447","author":"YJ Xu","year":"2019","unstructured":"Xu YJ, Zhou R, Zong JF, Lin WS, Tong S, Guo QJ, et al. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2\/NF-\u03baB pathway. Cancer Lett. 2019;447:33\u201340.","journal-title":"Cancer Lett"},{"issue":"46","key":"2340_CR53","doi-asserted-by":"publisher","first-page":"e2312595120","DOI":"10.1073\/pnas.2312595120","volume":"120","author":"TS Postler","year":"2023","unstructured":"Postler TS, Wang A, Brundu FG, Wang P, Wu Z, Butler KE, et al. A pan-cancer analysis implicates human NKIRAS1 as a tumor-suppressor gene. Proc Natl Acad Sci. 2023;120(46):e2312595120.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"2340_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13045-020-01000-2","volume":"13","author":"H Chang","year":"2020","unstructured":"Chang H, Zou Z. Targeting autophagy to overcome drug resistance: further developments. J Hematol Oncol. 2020;13(1):159.","journal-title":"J Hematol Oncol"},{"key":"2340_CR55","doi-asserted-by":"crossref","unstructured":"Chen J, Cao W, Huang X, Chen Q, Ye S, Qu J, et al. TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy. Blood Adv. 2023;7(19):5752\u20135770.","DOI":"10.1182\/bloodadvances.2022008241"},{"issue":"4","key":"2340_CR56","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/1878-0261.12641","volume":"14","author":"J Xia","year":"2020","unstructured":"Xia J, He Y, Meng B, Chen S, Zhang J, Wu X, et al. NEK2 induces autophagy-mediated bortezomib resistance by stabilizing Beclin-1 in multiple myeloma. Mol Oncol. 2020;14(4):763\u201378.","journal-title":"Mol Oncol"},{"issue":"9","key":"2340_CR57","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/s41388-021-02167-9","volume":"41","author":"H Li","year":"2022","unstructured":"Li H, Roy M, Liang L, Cao W, Hu B, Li Y, et al. Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1. Oncogene. 2022;41(9):1298\u2013308.","journal-title":"Oncogene"},{"issue":"1","key":"2340_CR58","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12964-024-01628-4","volume":"22","author":"T Li","year":"2024","unstructured":"Li T, Xiao P, Qiu D, Yang A, Chen Q, Lin J, et al. NCX1\/Ca2\u2009+\u2009promotes autophagy and decreases bortezomib activity in multiple myeloma through non-canonical NF\u03baB signaling pathway. Cell Communication Signaling: CCS. 2024;22(1):258.","journal-title":"Cell Communication Signaling: CCS"},{"issue":"17","key":"2340_CR59","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1182\/blood-2014-03-564534","volume":"124","author":"S Chen","year":"2014","unstructured":"Chen S, Zhang Y, Zhou L, Leng Y, Lin H, Kmieciak M, et al. A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis. Blood. 2014;124(17):2687\u201397.","journal-title":"Blood"},{"issue":"11","key":"2340_CR60","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1038\/leu.2015.157","volume":"29","author":"S Jagannathan","year":"2015","unstructured":"Jagannathan S, Abdel-Malek MAY, Malek E, Vad N, Latif T, Anderson KC, et al. Pharmacologic screens reveal Metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib. Leukemia. 2015;29(11):2184\u201391.","journal-title":"Leukemia"},{"issue":"3","key":"2340_CR61","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/leu.2015.289","volume":"30","author":"MA Frassanito","year":"2016","unstructured":"Frassanito MA, De Veirman K, Desantis V, Di Marzo L, Vergara D, Ruggieri S, et al. Halting pro-survival autophagy by TGF\u03b2 Inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients. Leukemia. 2016;30(3):640\u20138.","journal-title":"Leukemia"},{"issue":"12","key":"2340_CR62","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.7150\/thno.15584","volume":"6","author":"M Roy","year":"2016","unstructured":"Roy M, Liang L, Xiao X, Peng Y, Luo Y, Zhou W, et al. Lycorine downregulates HMGB1 to inhibit autophagy and enhances bortezomib activity in multiple myeloma. Theranostics. 2016;6(12):2209\u201324.","journal-title":"Theranostics"},{"issue":"3","key":"2340_CR63","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41419-020-2399-y","volume":"11","author":"D Verzella","year":"2020","unstructured":"Verzella D, Pescatore A, Capece D, Vecchiotti D, Ursini MV, Franzoso G, et al. Life, death, and autophagy in cancer: NF-\u03baB turns up everywhere. Cell Death Dis. 2020;11(3):210.","journal-title":"Cell Death Dis"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02340-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:40:11Z","timestamp":1757263211000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02340-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2340"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02340-7","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"16 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Ethics Committee of Central South University (CSU-2024-0341), and written informed consent was obtained from all patients before enrollment in the research program.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"346"}}